Cite
MLA Citation
Rachel M Glicksman et al.. “[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.” BMJ open, vol. 10, no. 4, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100137792185.0x00000b